New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 1 (1-2) , 61-66
- https://doi.org/10.1016/s1568-9972(01)00008-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcγ receptor ligationBlood, 2001
- Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptidesKidney International, 2001
- Proteinase 3 gene polymorphisms and Wegener's granulomatosisKidney International, 2000
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3Clinical and Experimental Immunology, 1995
- Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosisKidney International, 1995
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-α1-antitrypsin complexation to disease activity in Wegener's granulomatosisClinical and Experimental Immunology, 1993
- Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.The Journal of Experimental Medicine, 1993
- Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disordersClinical and Experimental Immunology, 1991